News about Manufacturing

Novartis Opens New Radioligand Therapy Plant in California under USD 23 Billion US Expansion Plan

Novartis has inaugurated its third US-based radioligand therapy (RLT) manufacturing facility in Carlsbad, California, expanding its production network to meet growing demand and maintain a 99.9 percent on-time delivery rate for patients across the western United States, Alaska, and Hawaii.

Manufacturing | 12/11/2025 | By Dineshwori |  132

Primrose Bio Launches Next-Gen RNA Polymerase for Self-Amplifying mRNA

Primrose Bio has introduced Prima RNApols ExTend Cap AU, an advanced RNA polymerase designed to enhance capping efficiency and reduce double-stranded RNA formation in the production of self-amplifying mRNA, improving yield and quality in mRNA manufacturing.

Manufacturing | 12/11/2025 | By Dineshwori |  111

Novartis Opens New California Plant to Boost Cancer Drug Production

Novartis has opened a new 10,000-square-foot manufacturing facility in Carlsbad, California, to produce advanced radioligand therapies (RLTs) for cancer treatment. These innovative therapies combine precision targeting with radioactive particles to attack cancer cells while minimizing damage to healthy tissue.

Manufacturing | 11/11/2025 | By Darshana |  143

Eli Lilly to Pour USD 1.2B into Puerto Rico Facility Expansion Amid USA Manufacturing Push

Eli Lilly announced plans to invest more than USD 1.2 billion to expand and modernise its Lilly del Caribe manufacturing site in Carolina, Puerto Rico, as part of its broader initiative to enhance pharmaceutical production in the United States.

Manufacturing | 03/11/2025 | By Darshana |  145

Codexis and Nitto Denko Avecia Partner to Advance Enzymatic Oligonucleotide Manufacturing

Under the agreement, Nitto Denko Avecia will evaluate Codexis’ ECO Synthesis™ Manufacturing Platform, an enzyme-catalysed alternative to traditional solid-phase oligonucleotide synthesis.

Manufacturing | 01/11/2025 | By Darshana |  233

Ajinomoto Bio-Pharma and Olon Forge Partnership to Advance Sustainable Biologics Manufacturing

Ajinomoto Bio-Pharma Services (Aji Bio-Pharma), a global leader in biopharmaceutical contract development and manufacturing, has entered into a strategic partnership with Olon S.p.A. to provide innovative, large-scale drug substance manufacturing solutions for pharmaceutical and biotechnology clients.

Manufacturing | 30/10/2025 | By Darshana |  151

Sai Life Sciences Set to Double Process R&D Capacity with New Facility in Hyderabad

The upcoming Process R&D Block at Sai Life Sciences will cover 100,000 sq. ft. across five floors, featuring 140 process chemistry fume hoods, an integrated satellite analytical lab, and dedicated peptide and oligo labs, supported by a 25,000 sq. ft. central analytical facility.

Manufacturing | 28/10/2025 | By Dineshwori |  125

Merck Commits More Than USD 70 Billion to USA Manufacturing and R&D Expansion

A central component of this investment is the construction of a USD 3 billion pharmaceutical manufacturing facility in Elkton, Virginia, which is expected to generate around 500 permanent jobs and several thousand construction roles.

Manufacturing | 21/10/2025 | By Darshana |  175

ACG Announces USD 200 Million Investment for Empty-Capsule Manufacturing In the US

ACG has announced a USD 200 million phased investment to establish its first empty-capsule manufacturing operations in the United States.

Manufacturing | 21/10/2025 | By Dineshwori |  194

Ipca Laboratories Expands Global Footprint with New German Subsidiary

Ipca Laboratories has announced the incorporation of its wholly owned subsidiary, Ipca Pharmaceuticals GmbH, in the Federal Republic of Germany with an initial paid-up capital of Euro 25,000.

Manufacturing | 16/10/2025 | By Dineshwori |  184